Literature DB >> 9935083

MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.

W E Bolch1, L G Bouchet, J S Robertson, B W Wessels, J A Siegel, R W Howell, A K Erdi, B Aydogan, S Costes, E E Watson, A B Brill, N D Charkes, D R Fisher, M T Hays, S R Thomas.   

Abstract

The availability of quantitative three-dimensional in vivo data on radionuclide distributions within the body makes it possible to calculate the corresponding nonuniform distribution of radiation absorbed dose in body organs and tissues. This pamphlet emphasizes the utility of the MIRD schema for such calculations through the use of radionuclide S values defined at the voxel level. The use of both dose point-kernels and Monte Carlo simulation methods is also discussed. PET and SPECT imaging can provide quantitative activity data in voxels of several millimeters on edge. For smaller voxel sizes, accurate data cannot be obtained using present imaging technology. For submillimeter dimensions, autoradiographic methods may be used when tissues are obtained through biopsy or autopsy. Sample S value tabulations for five radionuclides within cubical voxels of 3 mm and 6 mm on edge are given in the appendices to this pamphlet. These S values may be used to construct three-dimensional dose profiles for nonuniform distributions of radioactivity encountered in therapeutic and diagnostic nuclear medicine. Data are also tabulated for 131I in 0.1-mm voxels for use in autoradiography. Two examples illustrating the use of voxel S values are given, followed by a discussion of the use of three-dimensional dose distributions in understanding and predicting biologic response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935083

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  68 in total

1.  Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations.

Authors:  David M Howard; Kimberlee J Kearfott; Scott J Wilderman; Yuni K Dewaraja
Journal:  Cancer Biother Radiopharm       Date:  2011-09-22       Impact factor: 3.099

2.  When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

3.  A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.

Authors:  Michael Ljungberg; Katarina Sjögreen; Xiaowei Liu; Eric Frey; Yuni Dewaraja; Sven-Erik Strand
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

4.  Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

Authors:  Renaud Lhommel; Larry van Elmbt; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

Review 5.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

6.  Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Authors:  Elif Hindié; Christophe Champion; Paolo Zanotti-Fregonara; Domenico Rubello; Nicole Colas-Linhart; Laura Ravasi; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

7.  Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images.

Authors:  F Botta; A Mairani; R F Hobbs; A Vergara Gil; M Pacilio; K Parodi; M Cremonesi; M A Coca Pérez; A Di Dia; M Ferrari; F Guerriero; G Battistoni; G Pedroli; G Paganelli; L A Torres Aroche; G Sgouros
Journal:  Phys Med Biol       Date:  2013-11-21       Impact factor: 3.609

8.  Activity quantification combining conjugate-view planar scintigraphies and SPECT/CT data for patient-specific 3-D dosimetry in radionuclide therapy.

Authors:  Yannick Berker; Andreas Goedicke; Gerrit J Kemerink; Til Aach; Bernd Schweizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

Review 9.  Three-dimensional imaging-based radiobiological dosimetry.

Authors:  George Sgouros; Eric Frey; Richard Wahl; Bin He; Andrew Prideaux; Robert Hobbs
Journal:  Semin Nucl Med       Date:  2008-09       Impact factor: 4.446

10.  Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

Authors:  Arnaud Dieudonné; Robert F Hobbs; Rachida Lebtahi; Fabien Maurel; Sébastien Baechler; Richard L Wahl; Ariane Boubaker; Dominique Le Guludec; Georges Sgouros; Isabelle Gardin
Journal:  J Nucl Med       Date:  2012-12-18       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.